Mack Nelson Haynes

Array ( [id] => 4177165 [patent_doc_number] => 06019972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Peptides of human T cell reactive feline protein (TRFP)' [patent_app_type] => 1 [patent_app_number] => 8/300928 [patent_app_country] => US [patent_app_date] => 1994-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 47 [patent_no_of_words] => 49558 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/019/06019972.pdf [firstpage_image] =>[orig_patent_app_number] => 300928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876214 [patent_doc_number] => 05728569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Chicken anaemia agent vaccine' [patent_app_type] => 1 [patent_app_number] => 8/300688 [patent_app_country] => US [patent_app_date] => 1994-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5998 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728569.pdf [firstpage_image] =>[orig_patent_app_number] => 300688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3869095 [patent_doc_number] => 05824307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Human-murine chimeric antibodies against respiratory syncytial virus' [patent_app_type] => 1 [patent_app_number] => 8/290592 [patent_app_country] => US [patent_app_date] => 1994-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10354 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824307.pdf [firstpage_image] =>[orig_patent_app_number] => 290592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3608900 [patent_doc_number] => 05565202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Low enhancement serotype 2 vaccine for marek\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/289818 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4422 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565202.pdf [firstpage_image] =>[orig_patent_app_number] => 289818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878826 [patent_doc_number] => 05798099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'DNA encoding Derf II, the major mite allergen, host cells containing such DNA and method for producing Derf II' [patent_app_type] => 1 [patent_app_number] => 8/288888 [patent_app_country] => US [patent_app_date] => 1994-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3801 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798099.pdf [firstpage_image] =>[orig_patent_app_number] => 288888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850351 [patent_doc_number] => 05719263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => '230Kd antigen present in Leishmania species' [patent_app_type] => 1 [patent_app_number] => 8/282845 [patent_app_country] => US [patent_app_date] => 1994-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 5608 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719263.pdf [firstpage_image] =>[orig_patent_app_number] => 282845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729137 [patent_doc_number] => 05693496 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'DNA encoding the mouse and human PH30 beta chain protein' [patent_app_type] => 1 [patent_app_number] => 8/264101 [patent_app_country] => US [patent_app_date] => 1994-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 7863 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693496.pdf [firstpage_image] =>[orig_patent_app_number] => 264101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3454236 [patent_doc_number] => 05472696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-05 [patent_title] => 'Antigen of group B streptococci' [patent_app_type] => 1 [patent_app_number] => 8/259350 [patent_app_country] => US [patent_app_date] => 1994-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 15 [patent_no_of_words] => 6481 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/472/05472696.pdf [firstpage_image] =>[orig_patent_app_number] => 259350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071961 [patent_doc_number] => 05965400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'DNA encoding a truncated pneumogoccal surface protein (PspA)' [patent_app_type] => 1 [patent_app_number] => 8/247491 [patent_app_country] => US [patent_app_date] => 1994-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 10777 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965400.pdf [firstpage_image] =>[orig_patent_app_number] => 247491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3711923 [patent_doc_number] => 05616326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Recombinant canine adenovirus 2 (CAV-2)' [patent_app_type] => 1 [patent_app_number] => 8/247296 [patent_app_country] => US [patent_app_date] => 1994-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2832 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616326.pdf [firstpage_image] =>[orig_patent_app_number] => 247296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3654570 [patent_doc_number] => 05591434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'DNA sequence encoding surface protein of cryptosporidium parvum' [patent_app_type] => 1 [patent_app_number] => 8/229393 [patent_app_country] => US [patent_app_date] => 1994-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7497 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591434.pdf [firstpage_image] =>[orig_patent_app_number] => 229393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874183 [patent_doc_number] => 05763585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method of making MHC-peptide complexes using metal chelate affinity chromatography' [patent_app_type] => 1 [patent_app_number] => 8/227372 [patent_app_country] => US [patent_app_date] => 1994-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 16422 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763585.pdf [firstpage_image] =>[orig_patent_app_number] => 227372 [rel_patent_id] =>[rel_patent_doc_number] =>)